QL Block in Laparoscopic Myomectomy
Part of paid clinical trials in Beachwood, Ohio.
- Sponsor
- Joseph Findley MD
- Study ID
- NCT05979493
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Fibroid Uterus
- Postoperative Pain
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Bupivacain — DRUG30cc IM injection in each quadratus lumborum muscle (60cc total).
- Saline — DRUG30cc IM injection in each quadratus lumborum muscle (60cc total).
Study Details
This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.
Key Dates
- Start date
- Aug 24, 2024
- Status verified
- Jul 2025
- Primary completion
- Jul 1, 2026
- Completion
- Jul 3, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: QL Block with BupivacaineParticipants will get a QL block using 30cc Bupivacaine bilaterally in quadratus lumborum muscle (60cc total).
- Sham Comparator: ControlParticipants will get a sham injection of 30cc saline bilaterally in quadratus lumborum muscle (60cc total).
Primary Outcome Measure
Time in minutes from first analgesic request as measured by medical chart review [ Time Frame: Up to 24 hours ]
Central Contacts
- Catherine P Haering, BA3392011531
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Hospitals Ahuja Medical Center | Beachwood | Ohio | 44122 |
Find similar trials in Beachwood, OH
Related Studies
- Effects of Simvastatin on Uterine Leiomyoma SizePHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- Ketamine in Patients Undergoing TEVAR Procedures Receiving NCIPHASE2 · Recruiting · Sam Tyagi · Lexington, Kentucky
- Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic SurgeryRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce PainPHASE3 · Recruiting · University of California, San Francisco · San Francisco, California